Literature DB >> 11702224

Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene.

C Sergi1, R Penzel, J Uhl, S Zoubaa, H Dietrich, N Decker, P Rieger, J Kopitz, H F Otto, M Kiessling, M Cantz.   

Abstract

We report a Turkish family with parental consanguinity and at risk for sialidosis type II, an inherited autosomal recessive disorder caused by lysosomal alpha-N-acetyl-neuraminidase (sialidase, NEU1) deficiency. The proband was a premature male infant that presented with hydrops, hepatomegaly, respiratory distress syndrome, and anemia and that died of respiratory insufficiency 2 months after birth despite intensive care. An abnormally increased [14C]methylamine incorporation and an isolated deficiency of lysosomal alpha-N-acetyl-neuraminidase were found in cultured skin fibroblasts. A previous pregnancy of the mother terminated in a spontaneous abortion in the 13th week of gestation. A successive pregnancy showed hydrops fetalis, and an enzymatic assay of cultured amniotic fluid cells indicated a deficiency of alpha-N-acetyl-neuraminidase. Following pregnancy termination at 20 weeks gestation, light microscopy of fetal tissues revealed classic vacuolation not only in liver, bone marrow, brain, and kidney, but also in endocrine organs such as the thyroid gland, adrenal gland, hypophysis, and testes, and in the thymus. DNA analysis of the family showed that both the proband and the third sibling had a novel homozygous nonsense point mutation at nucleotide 87 in exon 1 of the alpha-N-acetyl-neuraminidase (neu1) gene causing a substitution of tryptophan at codon 29 by a termination codon (W29X). DNA sequencing of polymerase chain reaction products identified the parents as heterozygous carriers. To detect neu1 mRNA expression, a real-time reverse transcription/polymerase chain reaction was performed, and similar rates of neu1 mRNA expression were found in the fibroblasts of the fetus, the 2nd sibling, and in controls. The very early termination codon with complete loss of neuraminidase activity is probably the molecular basis of the unusually severe vacuolation pattern in this form of congenital sialidosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702224     DOI: 10.1007/s004390100592

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

Review 1.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 2.  Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients.

Authors:  A Caciotti; M Di Rocco; M Filocamo; S Grossi; F Traverso; A d'Azzo; C Cavicchi; A Messeri; R Guerrini; E Zammarchi; M A Donati; Amelia Morrone
Journal:  J Neurol       Date:  2009-07-01       Impact factor: 4.849

3.  Non-immune fetal hydrops: Are we doing the appropriate tests each time?

Authors:  W Kurdi
Journal:  J Prenat Med       Date:  2007-01

Review 4.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

5.  QTLs for murine red blood cell parameters in LG/J and SM/J F(2) and advanced intercross lines.

Authors:  Thomas B Bartnikas; Clarissa C Parker; Riyan Cheng; Dean R Campagna; Jackie E Lim; Abraham A Palmer; Mark D Fleming
Journal:  Mamm Genome       Date:  2012-02-10       Impact factor: 2.957

Review 6.  NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Authors:  Aiza Khan; Consolato M Sergi
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

7.  Promptly reporting of critical laboratory values in pediatrics: A work in progress.

Authors:  Consolato Sergi
Journal:  World J Clin Pediatr       Date:  2018-11-12

8.  Ascites in infantile onset type II Sialidosis.

Authors:  Kaoutar Tazi; Vanessa Guy-Viterbo; Alexander Gheldof; Aurélie Empain; Anne Paternoster; Corinne De Laet
Journal:  JIMD Rep       Date:  2022-06-03

9.  Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis.

Authors:  Alessandra d'Azzo; Eda Machado; Ida Annunziata
Journal:  Expert Opin Orphan Drugs       Date:  2015-04-13       Impact factor: 0.694

Review 10.  Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder.

Authors:  Aiza Khan; Consolato Sergi
Journal:  Diagnostics (Basel)       Date:  2018-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.